Curtis L. Cetrulo

Founder at Auxocell Laboratories, Inc.

54 year

Health Technology

Consumer Services

Profile

Curtis L.
Cetrulo is a medical consultant and founder of Auxocell Laboratories, Inc. which is founded in 2008.
He is currently an independent director at OptMed, Inc. since 2022 and an associate professor-surgery at Harvard Medical School since 2009.
Dr. Cetrulo received his doctorate degree from Tufts University School of Medicine in 1999.

Curtis L. Cetrulo active positions

Companies	Position	Start
OptMed, Inc. OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY.	Director/Board Member	30/04/2022
Harvard Medical School	Corporate Officer/Principal	31/12/2008
Auxocell Laboratories, Inc. Auxocell Laboratories, Inc. Medical SpecialtiesHealth Technology Part of BioStem Technologies, Inc., Auxocell Laboratories, Inc. is a company that manufactures solid tissue processing equipment. The company is based in Cambridge, MA. The company was founded by Kyle J. Cetrulo, Curtis L. Cetrulo, Barrett W. Bready, Rouzbeh R. Taghizadeh. Kyle J. Cetrulo has been the CEO since incorporation. Auxocell Laboratories was acquired by BioStem Technologies, Inc.	Founder	31/12/2007

All active positions of Curtis L. Cetrulo

Training of Curtis L. Cetrulo

Tufts University School of Medicine

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Curtis L. Cetrulo's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
OptMed, Inc. OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY.	Health Technology
Auxocell Laboratories, Inc. Auxocell Laboratories, Inc. Medical SpecialtiesHealth Technology Part of BioStem Technologies, Inc., Auxocell Laboratories, Inc. is a company that manufactures solid tissue processing equipment. The company is based in Cambridge, MA. The company was founded by Kyle J. Cetrulo, Curtis L. Cetrulo, Barrett W. Bready, Rouzbeh R. Taghizadeh. Kyle J. Cetrulo has been the CEO since incorporation. Auxocell Laboratories was acquired by BioStem Technologies, Inc.	Health Technology